Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

MM-093

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
(-)-Epigallocatechin gallate, (-)-Gossypol; Ad.hIFN-beta, AF-37702, Agatolimod sodium, Agomelatine, Alvocidib hydrochloride, ARC… Expand
Is this relevant?
Review
2007
Review
2007
  • Elena Dudich
  • Current opinion in molecular therapeutics
  • 2007
  • Corpus ID: 9338696
Merrimack Pharmaceuticals Inc (previously Atlantic Biopharmaceuticals) is developing MM-093 (formerly ABI-001), an injectable… Expand
Is this relevant?
2007
2007
BACKGROUND Rheumatoid arthritis (RA) tends to remit during pregnancy, with more patients achieving remission in the third… Expand
Is this relevant?
2007
2007
1-Octanol, 9vPnC-MnCc; Abiraterone acetate, Adalimumab, Adefovir dipivoxil, Alemtuzumab, Aliskiren fumarate, Aminolevulinic acid… Expand
Is this relevant?
2007
2007
  • Nature Clinical Practice Rheumatology
  • 2007
  • Corpus ID: 37188672
MM-093 significantly improved the mean disease activity score (DAS) 28 and the mean patient’s global assessment compared with… Expand
Is this relevant?
2007
2007
  • Nature Clinical Practice Rheumatology
  • 2007
  • Corpus ID: 39784635
MM-093 significantly improved the mean disease activity score (DAS) 28 and the mean patient’s global assessment compared with… Expand
Is this relevant?